FOLD EBITDA Growth
Amicus Therapeutics Inc · EBITDA Growth
FOLD EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported83.10%period ending
FOLD TTM EBITDA YoY % (-132.05% → 83.10%)
Year-over-year change
High-resolution chart · PNG
FOLD ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 83.0957% | |
| 744.6438% | |
| 181.9751% | |
| 166.2463% | |
| 131.9172% | |
| 93.0917% | |
| 71.5899% | |
| 51.7565% | |
| 53.8632% | |
| 37.3698% | |
| 39.5764% | |
| 23.8232% | |
| 1.6247% | |
| -8.9673% | |
| -12.8264% | |
| -2.755% | |
| 16.5069% | |
| 26.3529% | |
| 22.2193% | |
| 29.1723% | |
| 26.8703% | |
| 15.9017% | |
| 34.9217% | |
| 22.2533% | |
| -3.0372% | |
| 1.4305% | |
| 6.7687% | |
| 9.1263% | |
| 25.4188% | |
| 25.1927% | |
| -124.7848% | |
| -112.3404% | |
| -122.8704% | |
| -144.1284% | |
| -16.9741% | |
| -38.4518% | |
| -52.6914% | |
| -60.7347% | |
| -90.9606% | |
| -93.4936% | |
| -89.4138% | |
| -86.3893% | |
| -56.6524% | |
| -31.8452% | |
| -13.7822% | |
| 1.1328% | |
| 7.6589% | |
| -4.3307% | |
| -16.9378% | |
| -19.0018% | |
| -40.8765% | |
| -17.9605% | |
| -8.1776% | |
| 1.5435% | |
| 22.7676% | |
| 14.6726% | |
| 13.837% | |
| -1,034.9921% | |
| -2,183.7628% | |
| -1,038.4261% | |
| -1,200.4809% | |
| 91.4932% | |
| 94.9419% | |
| 89.4836% | |
| 90.2056% | |
| -26.6712% | |
| -10.3935% | |
| -4.2064% | |
| 4.7231% | |
| 4.1206% | |
| -1.6424% | |
| 2.4471% | |
| 3.8341% | |
| -8.1316% | |
| -29.9194% | |
| -68.2399% | |
| -132.0461% |